4-[2-[ [5-METHYL-1-(2-NAPHTALENYL)-1H-PYRAZOL-3-YL]OXY]ETHYL] MORPHOLINE SALTS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20130143884A1
SERIAL NO

13511715

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to 4-[-2-[[5-methyl-1-(2-naphthalenyl)-1H-pyrazol-3-yl]oxy]ethyl]morpholine salts, specifically to the hydrochloride, to pharmaceutical compositions comprising them, and to their use in therapy and/or prophylaxis of sigma receptor associated diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LABORATORIOS DEL DR ESTEVE S AAV MARE DE DEU DE MONSTSERRAT 221 - 08026 BARCELONA SPAIN

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cuberes-Altisent, Maria Rosa Sant Cugat del Valles Barcelona, ES 16 72
García-Couceiro, Urko Bilbao (Vizcaya), ES 1 7
Solå-Carandell, Lluis Altafulla (Tarragona), ES 1 7

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation